|
Wheeler, C; Khurshid, A; Ibrahim, J et al. (2001) Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). Leuk Lymphoma 40:499-509
|
|
Gong, J; Avigan, D; Chen, D et al. (2000) Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci U S A 97:2715-8
|
|
Chang, M S; Sasaki, H; Campbell, M S et al. (1999) HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation. J Biol Chem 274:36544-9
|
|
Teicher, B A; Ara, G; Keyes, S R et al. (1998) Acute in vivo resistance in high-dose therapy. Clin Cancer Res 4:483-91
|
|
Sehn, L H; Antin, J H; Shulman, L N et al. (1998) Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 91:717-23
|
|
Ayash, L J; Elias, A; Ibrahim, J et al. (1998) High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma. J Clin Oncol 16:1000-7
|
|
Teicher, B A; Ikebe, M; Ara, G et al. (1997) Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin. In Vivo 11:463-72
|
|
Gong, J; Chen, L; Chen, D et al. (1997) Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 4:1023-8
|
|
Wheeler, C; Eickhoff, C; Elias, A et al. (1997) High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Biol Blood Marrow Transplant 3:98-106
|
|
Holden, S A; Emi, Y; Kakeji, Y et al. (1997) Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants. Cancer Chemother Pharmacol 40:87-93
|
Showing the most recent 10 out of 87 publications
